LT4007B - Composition to prevent seasickness - Google Patents

Composition to prevent seasickness Download PDF

Info

Publication number
LT4007B
LT4007B LTIP1849A LTIP1849A LT4007B LT 4007 B LT4007 B LT 4007B LT IP1849 A LTIP1849 A LT IP1849A LT IP1849 A LTIP1849 A LT IP1849A LT 4007 B LT4007 B LT 4007B
Authority
LT
Lithuania
Prior art keywords
composition
symptoms
methyl
transport
preparation
Prior art date
Application number
LTIP1849A
Other languages
English (en)
Lithuanian (lt)
Inventor
Gyorgy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LTIP1849A publication Critical patent/LTIP1849A/xx
Publication of LT4007B publication Critical patent/LT4007B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Confectionery (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)
  • Steam Or Hot-Water Central Heating Systems (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Charge And Discharge Circuits For Batteries Or The Like (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
LTIP1849A 1986-12-19 1994-01-31 Composition to prevent seasickness LT4007B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick

Publications (2)

Publication Number Publication Date
LTIP1849A LTIP1849A (en) 1995-08-25
LT4007B true LT4007B (en) 1996-07-25

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1849A LT4007B (en) 1986-12-19 1994-01-31 Composition to prevent seasickness

Country Status (26)

Country Link
US (1) US4925878A (ro)
EP (1) EP0294441B1 (ro)
JP (1) JP2534553B2 (ro)
AT (1) ATE82847T1 (ro)
BG (1) BG51918A1 (ro)
CY (1) CY1740A (ro)
CZ (1) CZ277831B6 (ro)
DD (1) DD264851A5 (ro)
DE (1) DE3782935T2 (ro)
DK (1) DK464788D0 (ro)
ES (1) ES2009228A6 (ro)
FI (1) FI883837L (ro)
GE (1) GEP19970949B (ro)
GR (1) GR871953B (ro)
HK (1) HK105193A (ro)
HU (1) HU197510B (ro)
IL (1) IL84786A (ro)
LT (1) LT4007B (ro)
LV (1) LV10185B (ro)
MD (1) MD408C2 (ro)
MX (1) MX9203088A (ro)
PT (1) PT86406B (ro)
RU (1) RU1825314C (ro)
SK (1) SK278500B6 (ro)
UA (1) UA19281A1 (ro)
WO (1) WO1988004552A1 (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
EP1413299A3 (en) * 1991-04-04 2004-05-06 The University Of Toronto Innovations Foundation Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
ES2157330T3 (es) 1994-06-03 2001-08-16 Thejmde Trust Composicion que comprende aril-alquil-amina meta substituida, usos terapeuticos y diagnosticos.
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
AU723047B2 (en) 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
CA2214026C (en) * 1995-03-02 2007-10-16 R.P. Scherer Limited Pharmaceutical compositions comprising monoamine oxidase b inhibitors
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) * 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212484B (en) 1992-04-10 1996-07-29 Schott Glaswerke Lead-and bariumless crystalline glass with high light transmission

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212484B (en) 1992-04-10 1996-07-29 Schott Glaswerke Lead-and bariumless crystalline glass with high light transmission

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NO AUTHORS LISTED: "EVALUATION of drugs for protection against motion sickness aboard transport ships; report of study by Army, Navy, Air Force motion sickness team", J AM MED ASSOC., 1956, pages 755 - 760

Also Published As

Publication number Publication date
DE3782935T2 (de) 1993-04-08
CY1740A (en) 1995-10-20
GR871953B (en) 1988-04-19
LV10185A (lv) 1994-10-20
FI883837A0 (fi) 1988-08-18
EP0294441B1 (en) 1992-12-02
FI883837A7 (fi) 1988-08-18
ATE82847T1 (de) 1992-12-15
ES2009228A6 (es) 1989-09-16
JP2534553B2 (ja) 1996-09-18
DK464788A (da) 1988-08-18
PT86406A (en) 1988-01-01
GEP19970949B (en) 1997-03-31
HUT45196A (en) 1988-06-28
FI883837L (fi) 1988-08-18
LV10185B (en) 1995-04-20
DD264851A5 (de) 1989-02-15
JPH01501626A (ja) 1989-06-08
US4925878A (en) 1990-05-15
CS8709491A1 (en) 1990-05-14
UA19281A1 (uk) 1997-12-25
LTIP1849A (en) 1995-08-25
HU197510B (en) 1989-04-28
DK464788D0 (da) 1988-08-18
BG51918A1 (en) 1993-11-15
MX9203088A (es) 1992-07-01
SK278500B6 (en) 1997-07-09
WO1988004552A1 (en) 1988-06-30
EP0294441A1 (en) 1988-12-14
MD408C2 (ro) 1996-07-31
CZ277831B6 (en) 1993-06-16
PT86406B (pt) 1990-11-20
HK105193A (en) 1993-10-15
IL84786A (en) 1991-08-16
RU1825314C (ru) 1993-06-30
DE3782935D1 (de) 1993-01-14

Similar Documents

Publication Publication Date Title
LT4007B (en) Composition to prevent seasickness
DE68926169T2 (de) Heilmittel enthaltende matrize
DE3650488T2 (de) Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln
DE60131004T2 (de) Pharmazeutische zubereitungen gegen kopfschmerz, migräne, nausea und erbrechen
US11839600B2 (en) Neurodevelopmental disorder therapy
DE69926804T2 (de) Vorrichtungen zur behandlung und diagnose des restless leg syndroms
DE60011650T2 (de) Synergistische kombination von nk1-rezeptor antagonisten und gaba analogen
DE69131398T2 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
DE60217653T2 (de) Verwendung von Melatonin zur Behandlung von Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom
DE69122480T2 (de) Verwendung von Phenyläthanolaminotetralinen zur Herstellung eines antidepressiven und Antistress-Arzneimittels
JP2023526517A (ja) 運動失調症を治療するためのアセチルロイシンと４－アミノピリジン又はアセタゾラミドとの組合せ
DE2831728C2 (de) Arzneimittel zur Behandlung von Kopfschmerzen
DE3505743A1 (de) Bromocriptin enthaltende zusammensetzungen
Modarres-Sadeghi et al. Comparative efficacy and safety of intravenous and oral administration of a TRH analogue (RX77368) in motor neuron disease.
HK40083948A (en) A2-73 for treating angelman syndrome, williams syndrome smith-magenis syndrome and multiple sclerosis
EP0192098A2 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
Sebban et al. Dexfenfluramine profile in quantitative EEG and its topographical aspects
Wessely 111. Migräne
Hussain Benzhexol-induced hallucinosis
STATURE clinical Rounds
DE3507861A1 (de) Mittel zur behandlung der parkinsonschen-erkrankung bzw. des parkinsonismus
HK1155659B (en) Pharmaceutical composition for treatment of fibromyalgia
TH41275B (th) สารแขวนลอยที่มีน้ำของ 9-ไฮดรอกซิริสเพอริโดนแฟททีแอซิดเอสเทอร์
HK1155659A1 (en) Pharmaceutical composition for treatment of fibromyalgia

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19980131